Factors Involved in the Immunological Protection against Rabies Virus in Dogs in Spain.
One Health
factors affecting seroprevalence
immune protection against rabies virus in dogs
rabies vaccine
serum antibodies
Journal
Vaccines
ISSN: 2076-393X
Titre abrégé: Vaccines (Basel)
Pays: Switzerland
ID NLM: 101629355
Informations de publication
Date de publication:
11 Mar 2024
11 Mar 2024
Historique:
received:
22
01
2024
revised:
07
03
2024
accepted:
09
03
2024
medline:
28
3
2024
pubmed:
28
3
2024
entrez:
28
3
2024
Statut:
epublish
Résumé
Rabies, a viral disease spread by infected animal bites that causes encephalitis in humans and other mammals, is a neglected infectious disease present on all continents except Antarctica. Spain has been free of terrestrial rabies since 1978. However, due to its geographical situation, it represents a bridge for imported cases from an endemic continent such as Africa to Europe. Rabies vaccination in dogs is an essential preventive tool against this zoonosis. The aim of this study was to determine the state of the immune response against rabies virus in dogs in Spain and to demonstrate whether several factors that have been previously related to the influence of the seroprevalence of this species are involved here. The seroconversion level of this zoonotic virus was assessed in a total of 1060 animals. Indirect ELISA was used to obtain data for statistical analysis to evaluate the studied variables. Working under the concept of One Health, this study provides relevant information to be taken into consideration not only to prevent re-emergence in countries free of this disease but also for prevention and control in endemic countries.
Identifiants
pubmed: 38543927
pii: vaccines12030293
doi: 10.3390/vaccines12030293
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Gobierno de Aragón
ID : 0359